Monitoring patients with CLL on ibrutinib-based therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:13 3 months ago 59 Далее Скачать
Ibrutinib-based therapy superior for younger patients with previously untreated CLL compared wit... ecancer 2:51 6 years ago 115 Далее Скачать
Achieving undetectable MRD with ibrutinib plus venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 221 Далее Скачать
Emerging ibrutinib-based combinations in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 75 Далее Скачать
The outcomes of intensive treatment for patients with AML who have failed venetoclax-based therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:22 2 days ago 63 Далее Скачать
Venetoclax and ibrutinib based approaches in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:50 4 years ago 186 Далее Скачать
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ecancer 5:27 8 years ago 121 Далее Скачать
Selecting Patients for Treatment With Ibrutinib in CLL Targeted Oncology 2:14 6 years ago 569 Далее Скачать
MRD monitoring in CLL and implications for clinical practice VJHemOnc – Video Journal of Hematology & HemOnc 1:57 3 years ago 155 Далее Скачать
ASH 2018: Ibrutinib-based Therapy Versus FCR in Untreated Patients with CLL NE Live 4:25 6 years ago 354 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 639 Далее Скачать
CLL: Long-term updates on ibrutinib and idelalisib HMP Education 25:09 6 years ago 2 195 Далее Скачать
Case 3: Managing Ibrutinib-Associated Toxicities in CLL Targeted Oncology 3:58 4 years ago 177 Далее Скачать
The latest CLL treatments and therapies with Dr Jan Burger Leukaemia Foundation - Blood Cancer Information 50:25 5 years ago 2 846 Далее Скачать
Changing epigenetic markers in CLL patients on ibrutinib VJHemOnc – Video Journal of Hematology & HemOnc 2:36 7 years ago 396 Далее Скачать